Irinotecan-eluting beads

N/A

Report date: 2024/11/24 20:00:04
NME

Base Information

Drug NameIrinotecan-eluting beads
Drug Alias NameIrinotecan beadDEBIRIPARAGON BeadCM-BC-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsLiver NeoplasmsColorectal NeoplasmsCholangiocarcinoma +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsLiver NeoplasmsColorectal NeoplasmsCholangiocarcinoma +[4
Inactive IndicationsN/A

Other Information

ATC CodeL01CE02
Related LinksN/A